Age-Related Macular Degeneration Documentation Guide
Progressive degeneration of the macula causing central vision loss in older adults.
ICD-10 Codes: H35.30, H35.31, H35.32
Common Symptoms
- Central vision blurring
- Metamorphopsia
- Scotoma
- Difficulty reading
- Decreased color perception
Key Documentation Elements
- AMD type (dry/atrophic vs wet/neovascular)
- AREDS staging and risk category
- OCT findings (drusen, subretinal fluid, geographic atrophy)
- Anti-VEGF injection regimen and response (if wet)
- Visual acuity (best corrected) and functional assessment
Documentation Challenges
- Documenting dry vs wet AMD classification
- Recording OCT findings and drusen characteristics
- Capturing anti-VEGF injection history and response
- Tracking visual acuity trends and functional impact
Billing Considerations
- H35.30 (unspecified) vs H35.31 (dry) vs H35.32 (wet/exudative) coding
- Anti-VEGF intravitreal injection procedure billing
- OCT imaging and fluorescein angiography billing
Frequently Asked Questions
How is AMD classified in ICD-10 coding?
H35.30 is unspecified AMD, H35.31 is nonexudative (dry) AMD, and H35.32 is exudative (wet) AMD. Each includes laterality digits. Scribeable selects based on your documented OCT findings and clinical classification.
How does Scribeable document AMD treatment?
Scribeable captures visual acuity, OCT findings, anti-VEGF injection details, treatment intervals, and AREDS supplement use from your encounter, creating structured retinal disease management documentation.